Most people without insurance and with limited incomes qualify for the Abbvie PAP.

Family Size, Medication, and other special circumstances are considered by Abbvie when applying for their Prescription assistance.

Abbvie also offers a specific form for patients who have Medicare Part D coverage but are unable to afford their medication due to special circumstances.

Abbvie income guidelines (some medications vary):

Persons in Family Annual Income
1 $23,540
2 $31,860
3 $40,180
4 $48,500

Medications covered by the Patient Assistance Program:

AndroGel® (testosterone gel)

Creon® (pancrelipase delayed release capsules)

Depakote® (divalproex sodium delayed-release tablets)

Depakote® ER (divalproex sodium extended-release tablets)

Gengraf® Capsules (cyclosporine capsules, USP [MODIFIED])

HUMIRA® (adalimumab)

KALETRA® (lopinavir/ritonavir) Tablets

KALETRA® (lopinavir/ritonavir) Oral Solution

Lupaneta Pack® (leuprolide acetate for depot suspension and norethindrone acetate tablets)

LUPRON DEPOT® URO (leuprolide acetate)

LUPRON DEPOT® GYN (leuprolide acetate)

LUPRON DEPOT-PED® (leuprolide acetate)

Moderiba® (ribavirin)

Norvir® (ritonavir capsules) Soft Gelatin

Norvir® (ritonavir oral solution)

Norvir® (ritonavir) tablet for oral use

Synthroid® (levothyroxine sodium tablets, USP)

Tarka® (trandolapril/verapamil HCl ER tablets)

Phone: (706) 208 9700   Mail: